Our general manager and other executives participated in Japan and Korea Medicine Summit held by CCCMHPIE from April 9 to April 15.

In the morning of April 10, attendees participated in Sino-Japan Medicine Submit which was held by CCCMHPIE and Japan medicine trade association. In the submit, PMDA, Japan Generic Medicine Association, Japanese pharmaceutical enterprises communicated in depth on Japanese pharmaceutical laws and regulations, market access, trade and investment and transition of innovative technology.

On April 14, attendees participated in the pharmaceutical enterprises communication meeting which was held by CCCMHPIE, Korea and Chinese leader association and KPTA. They had a discuss on transition of innovative technology and introduction of product and other collaborative contents. In the morning of April 15, our company visited Korea medicine regulation association and famous pharmaceutical enterprise, HANDOK and had an in-depth discussion on pharmaceutical product registration, latest laws, regulations and policies and medicine trade and its distribution channel.

During this activity, our company had been invited to visit CPhI Japan and visited Japanese and Korean exhibitors and had a friendly negotiation with them. This activity prompted us to know the medicine market environment of Japan and Korea , helped our company to find trade and investment opportunity and it made a great achievement.